Gene Reports 

TL;DR: The genomic signature analysis demonstrates that a strong association between the time of sample collection, location of sample and accumulation of genetic diversity is found and heavily supports an intense requirement for additional prompt, inclusive investigations that combine genomic detail, epidemiological information and graph records of the clinical features of patients with COVID-19.

TL;DR: Modulation of the biosynthetic pathway genes of SMs could provide drought resistance, and expression analyses have revealed that genes encoding transcription factors such as MAT, MYB, ERF, CBL, CCR, and NAC play a crucial role in SM mediated drought response.

TL;DR: Interestingly, the key tumor-suppressor p53 protein will undergo degradation by virus-encoded E3 ubiquitin ligase Ring-finger and CHY zinc-finger domain-containing 1 (RCHY1) leading to an increased viral survival in host cells.

TL;DR: The present findings suggest that these FDA approved antiviral drugs can be subjected to repurposing against SARS-CoV-2 infection after verifying the in silico results through in vitro and in vivo studies.

TL;DR: The highly specific proteins screened out in the study, will presumably accelerate the unraveling of novel therapeutic drugs against S. epidermidis.